Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COGNEX CORPCGNX · Entity 3527 | Director | February 22, 2023 | February 23, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COGNEX CORP
Report date February 22, 2023 · Filed February 23, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,500 |
Ending reported balance
After 2023-02-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-02-22 · Exercise / conversion · Acquired 854 · Balance 36,354 Row 2 · 2023-02-23 · Sale · Disposed 854 · Balance 35,500 F1: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-02-22 | Direct | 3,415 |
Reported balance
After 2023-02-22 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-02-22 · Exercise / conversion · Disposed 854 · Balance 3,415 F2: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2024-02-16 | Direct | 1,519 |
Reported balance
Holding disclosure · report date 2023-02-22 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 1,519 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.94 · Expires 2030-02-18 | Direct | 13,800 |
Reported balance
Holding disclosure · report date 2023-02-22 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 13,800 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.49 · Expires 2029-02-19 | Direct | 10,400 |
Reported balance
Holding disclosure · report date 2023-02-22 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 10,400 |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.44 · Expires 2028-02-20 | Direct | 2,600 |
Reported balance
Holding disclosure · report date 2023-02-22 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 2,600 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
F3: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2023 Filed Feb 23, 2023 21:21 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 854 | $48.04 | $41,026.16 |
DisclosureSEC source: 0001963684-23-000008 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 F1 · kind: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 21:21 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 854 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001963684-23-000008 · edgardoc.xml · derivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,415 Underlying: Common Stock · 854 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 21:21 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 854 | $0.00 | $0.00 |
DisclosureSEC source: 0001963684-23-000008 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,354 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2023 Filed Feb 21, 2023 21:14 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 912 | $48.39 | $44,131.68 |
DisclosureSEC source: 0001194210-23-000004 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 F1 · kind: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:14 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 912 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001194210-23-000004 · edgardoc.xml · derivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,519 Underlying: Common Stock · 912 shares Expires 2024-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 16, 2021), respectively. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:14 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 912 | $0.00 | $0.00 |
DisclosureSEC source: 0001194210-23-000004 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,412 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:04 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,400 | $0.00 Strike: $56.44 | $0.00 |
DisclosureSEC source: 0001401616-23-000004 · edgardoc.xml · derivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 10,400 shares Expires 2028-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2018). Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:04 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 10,400 | $57.00 | $592,815.60 |
DisclosureSEC source: 0001401616-23-000004 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 F2 · kind: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:04 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 10,400 | $56.44 | $586,976.00 |
DisclosureSEC source: 0001401616-23-000004 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,600 | $0.00 Strike: $51.49 | $0.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · derivative · entry 12 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Common Stock · 15,600 shares Expires 2029-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F6 · derivative.exercise_date: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 19, 2019). Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 9,200 | $0.00 Strike: $50.94 | $0.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · derivative · entry 11 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,800 Underlying: Common Stock · 9,200 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options vest in five equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2020). Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $20.63 | $0.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · derivative · entry 10 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,000 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F4 · derivative.exercise_date: The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 17, 2015). Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $19.66 | $0.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · derivative · entry 9 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,000 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 18, 2014). Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 9,200 | $52.00 | $478,400.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · nonDerivative · entry 8 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,108 F2 · kind: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 9,200 | $50.94 | $468,648.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · nonDerivative · entry 7 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,308 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 15,600 | $52.01 | $811,395.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · nonDerivative · entry 6 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,108 F2 · kind: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 15,600 | $51.49 | $803,244.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · nonDerivative · entry 5 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,708 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 26,000 | $51.40 | $1,336,400.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · nonDerivative · entry 4 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,108 F2 · kind: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 26,000 | $20.63 | $536,250.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · nonDerivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 26,000 | $51.40 | $1,336,400.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,108 F2 · kind: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:37 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 26,000 | $19.66 | $511,030.00 |
DisclosureSEC source: 0001401616-22-000004 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These stock option exercises were effected pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 16:44 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $38.39 | $0.00 |
DisclosureSEC source: 0001401616-22-000002 · edgardoc.xml · derivative · entry 6 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,000 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 21, 2017). Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 16:44 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 26,000 | $0.00 Strike: $16.72 | $0.00 |
DisclosureSEC source: 0001401616-22-000002 · edgardoc.xml · derivative · entry 5 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,000 shares Expires 2026-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 12, 2016). Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 16:44 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 26,000 | $50.00 | $1,300,000.00 |
DisclosureSEC source: 0001401616-22-000002 · edgardoc.xml · nonDerivative · entry 4 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,108 Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 16:44 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 26,000 | $38.39 | $998,140.00 |
DisclosureSEC source: 0001401616-22-000002 · edgardoc.xml · nonDerivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 16:44 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 26,000 | $50.00 | $1,300,000.00 |
DisclosureSEC source: 0001401616-22-000002 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,108 Read SEC document |
| December 12, 2022 Filed Dec 14, 2022 16:44 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 26,000 | $16.72 | $434,720.00 |
DisclosureSEC source: 0001401616-22-000002 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2022 Filed Feb 3, 2023 21:03 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 608 | $70.05 | $42,591.01 |
DisclosureSEC source: 0001401616-23-000002 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 19:57 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 4,269 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001806043-22-000021 · edgardoc.xml · derivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,269 Underlying: Common Stock · 4,269 shares Expires 2025-02-22 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 22, 2022), respectively. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 20:31 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionRestricted Stock Unit · Derivative | 608 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001806043-22-000010 · edgardoc.xml · derivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,431 Underlying: Common Stock · 608 shares Expires 2024-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 16, 2021), respectively. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 20:31 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0001806043-22-000010 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 20:31 UTC | COGNEX CORP CGNX · Entity 3527 | GrantRestricted Stock Unit · Derivative | 3,039 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001401616-21-000002 · edgardoc.xml · derivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,039 Underlying: Common Stock · 3,039 shares Expires 2024-02-16 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the Transaction Date, respectively. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 16:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,670 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0001721515-20-000017 · edgardoc.xml · derivative · entry 6 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,670 shares Expires 2023-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 16:46 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 14,670 | $72.13 | $1,058,189.64 |
DisclosureSEC source: 0001721515-20-000017 · edgardoc.xml · nonDerivative · entry 4 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 16:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 14,670 | $10.53 | $154,438.43 |
DisclosureSEC source: 0001721515-20-000017 · edgardoc.xml · nonDerivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 16:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 330 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0001721515-20-000017 · edgardoc.xml · derivative · entry 5 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,670 Underlying: Common Stock · 330 shares Expires 2023-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 16:46 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 330 | $72.00 | $23,760.00 |
DisclosureSEC source: 0001721515-20-000017 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 Read SEC document |
| November 13, 2020 Filed Nov 17, 2020 16:46 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 330 | $10.53 | $3,474.08 |
DisclosureSEC source: 0001721515-20-000017 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,830 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 15:39 UTC | COGNEX CORP CGNX · Entity 3527 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 23,000 | $0.00 Strike: $50.94 | $0.00 |
DisclosureSEC source: 0001401616-20-000005 · edgardoc.xml · derivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2030-02-18 Read SEC document |
| October 30, 2019 Filed Oct 31, 2019 14:36 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $10.53 | $0.00 |
DisclosureSEC source: 0001721515-19-000002 · edgardoc.xml · derivative · entry 6 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2023-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Oct 31, 2019 14:36 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $8.40 | $0.00 |
DisclosureSEC source: 0001721515-19-000002 · edgardoc.xml · derivative · entry 5 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Oct 31, 2019 14:36 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 15,000 | $51.87 | $777,984.00 |
DisclosureSEC source: 0001721515-19-000002 · edgardoc.xml · nonDerivative · entry 4 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Read SEC document |
| October 30, 2019 Filed Oct 31, 2019 14:36 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 15,000 | $10.53 | $157,912.50 |
DisclosureSEC source: 0001721515-19-000002 · edgardoc.xml · nonDerivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 30, 2019 Filed Oct 31, 2019 14:36 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 15,000 | $51.87 | $777,984.00 |
DisclosureSEC source: 0001721515-19-000002 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Read SEC document |
| October 30, 2019 Filed Oct 31, 2019 14:36 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 15,000 | $8.40 | $125,962.50 |
DisclosureSEC source: 0001721515-19-000002 · edgardoc.xml · nonDerivative · entry 1 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 26, 2019 18:41 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $8.40 | $0.00 |
DisclosureSEC source: 0001401616-19-000001 · edgardoc.xml · derivative · entry 7 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2021-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 26, 2019 18:41 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.67 | $0.00 |
DisclosureSEC source: 0001401616-19-000001 · edgardoc.xml · derivative · entry 5 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2021-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 26, 2019 18:41 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 15,000 | $53.18 | $797,656.50 |
DisclosureSEC source: 0001401616-19-000001 · edgardoc.xml · nonDerivative · entry 4 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Read SEC document |
| February 26, 2019 Filed Feb 26, 2019 18:41 UTC | COGNEX CORP CGNX · Entity 3527 | Exercise / conversionCommon Stock | 15,000 | $8.40 | $125,962.50 |
DisclosureSEC source: 0001401616-19-000001 · edgardoc.xml · nonDerivative · entry 3 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2019 Filed Feb 26, 2019 18:41 UTC | COGNEX CORP CGNX · Entity 3527 | SaleCommon Stock | 15,000 | $53.18 | $797,656.50 |
DisclosureSEC source: 0001401616-19-000001 · edgardoc.xml · nonDerivative · entry 2 KRANTZ THEODOR · CIK 0001401616 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.